The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

被引：0
|
作者：
Emine Acar
Özhan Özdoğan
Ayşegül Aksu
Erkan Derebek
Recep Bekiş
Gamze Çapa Kaya
机构：
[1] İzmir Kâtip Çelebi University,Department of Nuclear Medicine, Ataturk Training and Research Hospital
[2] Dokuz Eylul University,Department of Translational Oncology, Institute of Health Sciences
[3] Dokuz Eylul University,Department of Nuclear Medicine, School of Medicine
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
PSMA; MTV; TLG; Tumor volume; Precision medicine; Theranostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 688
页数：7
相关论文
共 38 条
  • [1] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Acar, Emine
    Ozdogan, Ozhan
    Aksu, Aysegul
    Derebek, Erkan
    Bekis, Recep
    Kaya, Gamze Capa
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (09) : 681 - 688
  • [2] Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results
    Acar, Emine
    Sonmezer, Burak
    Derebek, Erkan
    Bekis, Recep
    Ozdogan, Ozhan
    Kaya, Gamze Capa
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 158 - 164
  • [3] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [4] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 8
  • [5] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [6] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Philipp E. Hartrampf
    Thomas Hüttmann
    Anna Katharina Seitz
    Hubert Kübler
    Sebastian E. Serfling
    Wiebke Schlötelburg
    Kerstin Michalski
    Steven P. Rowe
    Martin G. Pomper
    Andreas K. Buck
    Uta Eberlein
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3465 - 3474
  • [7] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Huettmann, Thomas
    Seitz, Anna Katharina
    Kuebler, Hubert
    Serfling, Sebastian E.
    Schloetelburg, Wiebke
    Michalski, Kerstin
    Rowe, Steven P.
    Pomper, Martin G.
    Buck, Andreas K.
    Eberlein, Uta
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3465 - 3474
  • [8] Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received 177Lu PSMA I&T therapy
    Bulbul, Ogun
    Unek, Ilkay Tugba
    Kefi, Aykut
    Tuna, Emine Burcin
    Bekis, Recep
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03) : 229 - 239
  • [9] Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
    Philipp E. Hartrampf
    Anna Katharina Seitz
    Franz-Xaver Weinzierl
    Sebastian E. Serfling
    Andreas Schirbel
    Steven P. Rowe
    Hubert Kübler
    Andreas K. Buck
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4262 - 4270
  • [10] Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Feuerecker, Benedikt
    Chantadisai, Maythinee
    Allmann, Anne
    Tauber, Robert
    Allmann, Jakob
    Steinhelfer, Lisa
    Rauscher, Isabel
    Wurzer, Alexander
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    d'Alessandria, Calogero
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 833 - 839
1234